Physician profile
Jay Steven Cohen
NPI 1104806603
$556,314.30
in general payments reported to CMS, 2019-2025
45 companies · $140K in 2025
The $140K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91K · 2020: $21K · 2021: $31K · 2022: $81K · 2023: $87K · 2024: $105K · 2025: $140K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $265K · Travel and Lodging: $39K · Food and Beverage: $14K · Honoraria: $11K · Consulting Fee: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $264,988.50 |
| Travel and Lodging | $38,661.10 |
| Food and Beverage | $14,283.68 |
| Honoraria | $10,935.00 |
| Consulting Fee | $2,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $216,459.59 | 2021-2025 | |
| Abbvie INC. | $84,433.78 | 2019-2023 | Lo Loestrin Fe |
| Myovant Sciences INC. | $61,761.14 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47,324.05 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $43,956.81 | 2023-2025 | Myfembree |
| Pfizer INC. | $34,285.85 | 2019-2024 | |
| Biogen, INC. | $28,772.65 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $27,479.77 | 2019-2022 | |
| Duchesnay USA Incorporated | $5,421.41 | 2019 | |
| Becton, Dickinson and Company | $1,420.00 | 2019-2022 | |
| Scynexis, INC. | $1,152.93 | 2022 | |
| Exeltis, USA INC. | $843.20 | 2019-2024 | Slynd |
| Hologic Sales and Service, LLC | $342.81 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Allergan, INC. | $275.11 | 2019-2020 | |
| Evofem Biosciences, INC. | $271.74 | 2020-2024 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $253.33 | 2021 | |
| Astellas Pharma US INC | $228.55 | 2023-2025 | Veozah |
| Daiichi Sankyo INC. | $192.65 | 2019-2023 | Injectafer |
| Aspira Women'S Health INC | $162.45 | 2019-2020 | |
| Exact Sciences Corporation | $111.79 | 2023-2024 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $111.43 | 2019-2020 | |
| Avion Pharmaceuticals | $105.60 | 2019-2022 | |
| Shield Therapeutics INC | $97.02 | 2022-2025 | |
| Ethicon US, LLC | $92.54 | 2023-2025 | Dermabond Prineo, Ethicon, Enseal |
| Lupin INC. | $67.25 | 2019-2021 | |
| Amgen INC. | $63.21 | 2020-2021 | |
| Organon LLC | $60.51 | 2022-2023 | |
| Millicent US INC | $59.93 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Merck Sharp & Dohme LLC | $58.02 | 2019-2020 | |
| Biotissue Holdings INC. | $56.12 | 2023-2024 | |
| Radius Health, INC. | $53.20 | 2019 | |
| Intra-Sana Laboratories | $43.70 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Channel Medsystems, INC. | $36.39 | 2023 | |
| Coopersurgical, INC. | $34.97 | 2020-2023 | Endosee |
| Optumhealth Care Solutions, LLC | $28.89 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Astellas Pharma Global Development | $28.00 | 2024 | Veozah |
| Pharmacosmos Therapeutics INC. | $26.43 | 2023 | Monoferric |
| Renovia INC | $24.33 | 2020 | |
| Agile Therapeutics, INC. | $22.93 | 2021 | |
| Medtronic, INC. | $22.85 | 2025 | Truclear |
| Mylan Pharmaceuticals INC. | $17.99 | 2019 | |
| Organogenesis INC. | $17.17 | 2024 | |
| Amag Pharmaceuticals, INC. | $14.97 | 2019 | |
| Roche Diagnostics Corporation | $13.27 | 2019 | |
| Meditrina | $7.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$12,600.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.